SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Guangzhou Innogen Signs Licensing Deal Worth Over $1 Billion

The Hong Kong-listed company signed a licensing deal for a diabetes drug valued at more than $1 billion.

Related stories